EVGN
NASDAQ HealthcareEvogene Ltd. - Ordinary Shares
Biotechnology
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
�� 市场数据
| 价格 | $0.59 |
|---|---|
| 成交量 | 24,623,394 |
| 市值 | 6.14M |
| 贝塔系数 | 0.800 |
| RSI（14日） | 22.6 超卖 |
| 200日均线 | $1.02 |
| 50日均线 | $0.77 |
| 52周最高 | $2.42 |
| 52周最低 | $0.52 |
| Forward P/E | -0.74 |
| Price / Book | -65.57 |
🎯 投资策略评分
EVGN 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🔪 Falling Knife (98/100) — 此策略 逆向投资（超卖 + 低于移动均线）.
评分最低的策略： 🎈 Over-Hyped (3/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 EVGN in your text
粘贴任何文章、记录或帖子 — 工具将提取 EVGN 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-06-02.